Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression

Clinical practice and data from literature indicate that up to 30% of the patients suffering from depression meet criteria for treatment-resistant depression. In the past decade, interest in the use of NMDA receptor modulators in the treatment of treatment-resistant depression is increasing. The use...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Psychiatria polska 2012-03, Vol.46 (2), p.283-294
Hauptverfasser:	Gosek, Paweł, Chojnacka, Magdalena, Bieńkowski, Przemysław, Swiecicki, Łukasz
Format:	Artikel
Sprache:	pol
Schlagworte:	Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use Cognition - drug effects Depressive Disorder, Treatment-Resistant - drug therapy Depressive Disorder, Treatment-Resistant - prevention & control Humans Ketamine - pharmacology Ketamine - therapeutic use Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!